Rigel Pharmaceuticals Inc (RIGL)

Investing Cash Flow

-$49.06M

TTM · Period ending: · USD

RIGL logo

RIGL Investing Cash Flow

Latest reported-$49.06M
RIGL TTM Cash from Investing (-$21.15M → -$49.06M)
High-resolution chart · PNG

RIGL investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Rigel Pharmaceuticals Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-49,059,000
-89,788,000
-92,365,000
-77,917,000
-40,940,000
-6,735,000
4,130,000
8,170,000
3,198,000
-4,761,000
-4,297,000
21,175,000
32,800,000
50,925,000
72,777,000
60,667,000
5,815,000
-64,939,000
-80,036,000
-77,813,000
-13,888,000
30,537,000
47,466,000
31,138,000
11,316,000
1,878,000
-23,656,000
-13,946,000
2,203,000
673,000
24,964,000
-12,369,000
-20,663,000
3,895,000
-19,473,000
17,878,000
20,710,000
31,502,000
24,881,000
35,520,000
55,773,000
28,331,000
44,613,000
48,822,000
25,434,000
61,983,000
62,932,000
69,453,000
77,101,000
57,054,000
72,380,000
-59,388,000
-55,215,000
-39,450,000
-39,051,000
87,073,000
56,496,000
-74,454,000
-62,848,000
-104,639,000
-84,270,000
-39,613,000
-53,403,000
-86,778,000
-100,668,000
-26,787,000
-30,664,000
40,512,000
78,273,000
36,380,000
-26,970,000
-30,860,000
-77,461,000
-61,874,000
-7,793,000
-15,028,000
-733,000
16,861,000
3,948,000
-25,301,000
-12,079,000
-7,073,000
-2,151,000
28,744,000
23,188,000
-8,105,000
-25,805,000
-34,480,000
-75,424,000
-51,657,000
-37,306,000
-27,245,000
26,547,000
26,922,000
19,491,000
17,386,000
4,379,000
-6,361,000
-21,150,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.